Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-06-24 17:15 CEST (UTC+2h)

Two-stage design and 'forced bioequivalence' [Two-Stage / GS Designs]

posted by Mikalai - Belarus, 2018-06-06 08:28  - Posting: # 18854
Views: 648

(edited by Mikalai on 2018-06-06 08:44)

Dear all,
We plan to conduct a sequential (two stage) BE study, and I am concerned with "forced bioequivalence". Specifically, if we obtain non-equivalent results in the first stage with very low power and should recruit more volunteers, how can we protect ourselves from getting into "forced bioequivalence"? In other words, how can we differentiate between underpowered trials and non-equivalent results in the sequential BE? And how can we put this (protection against "forced bioequivalence") in the protocol not to raise many questions from regulators?
Any suggestions and advice will be appreciated.
Sincerely,
Mikalai

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,425 posts in 3,913 threads, 1,176 registered users;
online 30 (1 registered, 29 guests [including 21 identified bots]).

There are no dangerous thoughts;
thinking itself is dangerous.    Hannah Arendt

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed